Last reviewed · How we verify
Determination of the clinical and biological characteristics
Determination of the clinical and biological characteristics is a Biologic drug developed by University Hospital, Rouen. It is currently in Phase 2 development.
At a glance
| Generic name | Determination of the clinical and biological characteristics |
|---|---|
| Sponsor | University Hospital, Rouen |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- PET/CT-Guided Biological Target Volume Delineation and Dose Optimization for Radioactive Seed Implantation Therapy in Malignant Tumors (NA)
- Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD) (NA)
- Insulin Resistance in Multiple System Atrophy (NA)
- NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria
- Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children (NA)
- Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes (NA)
- BIOpsychosocial Approach of the CAncer-RElated FAtigue (BIOCARE FActory) (NA)
- Assessing Gene-Environment Interactions in Clinical Presentation of Nevi and Melanoma (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Determination of the clinical and biological characteristics CI brief — competitive landscape report
- Determination of the clinical and biological characteristics updates RSS · CI watch RSS
- University Hospital, Rouen portfolio CI
Frequently asked questions about Determination of the clinical and biological characteristics
What is Determination of the clinical and biological characteristics?
Determination of the clinical and biological characteristics is a Biologic drug developed by University Hospital, Rouen.
Who makes Determination of the clinical and biological characteristics?
Determination of the clinical and biological characteristics is developed by University Hospital, Rouen (see full University Hospital, Rouen pipeline at /company/university-hospital-rouen).
What development phase is Determination of the clinical and biological characteristics in?
Determination of the clinical and biological characteristics is in Phase 2.